共 50 条
- [42] Mucosal healing and histological remission in paediatric ulcerative colitis: Does the target change the outcomes? JOURNAL OF CROHNS & COLITIS, 2018, 12 : S211 - S211
- [45] Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis JOURNAL OF CROHNS & COLITIS, 2017, 11 (09): : 1085 - 1089
- [47] Long-Term Endoscopic and Histological Outcomes of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis With up to 3 Years of Treatment AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1042 - S1043
- [48] Long-term outcome of ulcerative colitis in pediatric patients who achieved mucosal and histological healing: a real-life referral center experience JOURNAL OF CROHNS & COLITIS, 2022, 16 : I407 - I407
- [49] Long-term outcome of ulcerative colitis in pediatric patients who achieved mucosal and histological healing: a real-life referral center experience JOURNAL OF CROHNS & COLITIS, 2022, 16 : I407 - I407
- [50] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension JOURNAL OF CROHNS & COLITIS, 2021, 15 : S113 - S114